6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
17m ago	Vornado Realty Trust to Purchase 49% Interest in Park Avenue Plaza from Closer Properties
17m ago	Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the First Quarter Ended March 31, 2026
17m ago	Stoneridge's MirrorEye® Camera Monitor System Continues Strong Momentum, Achieving Record Global Sales and Production Milestones
17m ago	Atico Mining Produces 2.09 Million Pounds of Cu and 2,108 Ounces of Au in First Quarter 2026
18m ago	Markel Group reports 2026 first quarter results

About

Mesoblast Ltd (AU:MSB) — investor relations, events, news, and company updates on 6ix.

Latest News

Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION

Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation

Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy

Ryoncil Net Revenue for the Quarter Increases to US$30.3M

Financials

Revenue

A$65.38 M

Market Cap

A$2.92 B

EPS

-0.11

Community Chat

Ask AI